Michael R King

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 27

Top Topics

Natural Killer Cells

Top Venues

Nanoscale advances

Annals of biomedical engineering

Communications biology

This page only lists publications with an associated author ORCID identifier.

Publications

Abigail R Fabiano, Spencer C Robbins, Samantha V Knoblauch, Schyler J Rowland, Jenna A Dombroski, Michael R King
Multiplex, high-throughput method to study cancer and immune cell mechanotransduction. Communications biology 7 (1) (2024)
Abigail R Fabiano, Spencer C Robbins, Samantha V Knoblauch, Schyler J Rowland, Jenna A Dombroski, Michael R King
Multiplex, high-throughput method to study cancer and immune cell mechanotransduction. Communications biology 7 (1) (2024)
Shankar Subramaniam, Metin Akay, Mark A Anastasio, Vasudev Bailey, David A Boas, Ashutosh Chilkoti, Jennifer R Cochran, Vicki L Colvin, Tejal A Desai, James S Duncan, Frederick H Epstein, Stephanie I Fraley, Cecilia Maria Giachelli, Kathryn Jane Grande-Allen, Jordan J Green, Xiang-Dong Edward Guo, Isaac B Hilton, Jay D Humphrey, Chris R Johnson, George Em Karniadakis, Michael R King, Robert F Kirsch, Sanjay Kumar, Cato T Laurencin, Song Li, Richard L Lieber, Nigel H Lovell, Prashant Mali, Stephanie A Pasquesi, David F Meaney, Brenda M Ogle, Bernhard O Palsson, Nicholas A Peppas, Eric J Perreault, Richard D Rabbitt, Lori A Setton, Lonnie D Shea, Sanjeev G Shroff, Kirk Shung, Andreas Savas Tolias, Marjolein C H van der Meulen, Shyni Varghese, Gordana Vunjak-Novakovic, John A White, Raimond L Winslow, Jianyi Jay Zhang, Kun Zhang, Charles Zukoski
Grand Challenges at the Interface of Engineering and Medicine. IEEE open journal of engineering in medicine and biology 5 (2024)
Abigail R Fabiano, Spencer C Robbins, Samantha V Knoblauch, Schyler J Rowland, Jenna A Dombroski, Michael R King
Multiplex, high-throughput method to study cancer and immune cell mechanotransduction. Communications biology 7 (1) (2024)
Joshua D Greenlee, Zhenjiang Zhang, Tejas Subramanian, Kevin Liu, Michael R King
TRAIL-conjugated liposomes that bind natural killer cells to induce colorectal cancer cell apoptosis. Journal of biomedical materials research. Part A (2023)
Jenna A Dombroski, Monika Antunovic, Kerry R Schaffer, Paula J Hurley, Michael R King
Activation of Dendritic Cells Isolated from the Blood of Patients with Prostate Cancer by Ex Vivo Fluid Shear Stress Stimulation. Current protocols 3 (12) (2023)
Zhenjiang Zhang, Michael R King
Tuning of TRAIL clustering on the surface of nanoscale liposomes by phase separation. Nanoscale advances 6 (2) (2023)
Maria Lopez-Cavestany, Olivia A Wright, Ava M Cassidy, Alexandria T Carter, Michael R King
Dual Affinity Nanoparticles for the Transport of Therapeutics from Carrier Cells to Target Cells under Physiological Flow Conditions. ACS omega 8 (45) (2023)
Zhenjiang Zhang, Michael R King
Tuning of TRAIL clustering on the surface of nanoscale liposomes by phase separation. Nanoscale advances 6 (2) (2023)
Zhenjiang Zhang, Michael R King
Tuning of TRAIL clustering on the surface of nanoscale liposomes by phase separation. Nanoscale advances 6 (2) (2023)
Zhenjiang Zhang, Michael R King
Tuning of TRAIL clustering on the surface of nanoscale liposomes by phase separation. Nanoscale advances 6 (2) (2023)
Samantha V Knoblauch, Shanay H Desai, Jenna A Dombroski, Nicole S Sarna, Jacob M Hope, Michael R King
Chemical Activation and Mechanical Sensitization of Piezo1 Enhance TRAIL-Mediated Apoptosis in Glioblastoma Cells. ACS omega 8 (19) (2023)
Jacob M Hope, Jenna A Dombroski, Rebecca S Pereles, Maria Lopez-Cavestany, Joshua D Greenlee, Samantha C Schwager, Cynthia A Reinhart-King, Michael R King
Fluid shear stress enhances T cell activation through Piezo1. BMC biology 20 (1) (2022)
Michael R King
The Future of AI in Medicine: A Perspective from a Chatbot. Annals of biomedical engineering 51 (2) (2022)
Joshua D Greenlee, Michael R King
A syngeneic MC38 orthotopic mouse model of colorectal cancer metastasis. Biology methods & protocols 7 (1) (2022)
Michael R King
The Future of AI in Medicine: A Perspective from a Chatbot. Annals of biomedical engineering 51 (2) (2022)
Michael R King
The Future of AI in Medicine: A Perspective from a Chatbot. Annals of biomedical engineering (2022)
Michael R King
The Future of AI in Medicine: A Perspective from a Chatbot. Annals of biomedical engineering 51 (2) (2022)
Richard d'Arcy, Farah El Mohtadi, Nora Francini, Carlisle R DeJulius, Hyunmoon Back, Arianna Gennari, Mike Geven, Maria Lopez-Cavestany, Zulfiye Yesim Turhan, Fang Yu, Jong Bong Lee, Michael R King, Leonid Kagan, Craig L Duvall, Nicola Tirelli
A Reactive Oxygen Species-Scavenging 'Stealth' Polymer, Poly(thioglycidyl glycerol), Outperforms Poly(ethylene glycol) in Protein Conjugates and Nanocarriers and Enhances Protein Stability to Environmental and Biological Stressors. Journal of the American Chemical Society 144 (46) (2022)
Korie A Grayson, Nidhi Jyotsana, Nerymar Ortiz-Otero, Michael R King
Overcoming TRAIL-resistance by sensitizing prostate cancer 3D spheroids with taxanes. PloS one 16 (3) (2021)
Jacob M Hope, Matthew R Bersi, Jenna A Dombroski, Andrea B Clinch, Rebecca S Pereles, W David Merryman, Michael R King
Circulating prostate cancer cells have differential resistance to fluid shear stress-induced cell death. Journal of cell science 134 (4) (2021)
Joshua D Greenlee, Maria Lopez-Cavestany, Nerymar Ortiz-Otero, Kevin Liu, Tejas Subramanian, Burt Cagir, Michael R King
Oxaliplatin resistance in colorectal cancer enhances TRAIL sensitivity via death receptor 4 upregulation and lipid raft localization. eLife 10 (2021)
Nerymar Ortiz-Otero, Jocelyn R Marshall, Bradley W Lash, Michael R King
Platelet mediated TRAIL delivery for efficiently targeting circulating tumor cells. Nanoscale advances 2 (9) (2020)
Zhenjiang Zhang, Su Bin Hahn, Thong M Cao, Michael R King
A simplified method for the efficient purification and refolding of recombinant human TRAIL. Biotechnology progress 36 (5) (2020)
Joshua D Greenlee, Michael R King
Engineered fluidic systems to understand lymphatic cancer metastasis. Biomicrofluidics 14 (1) (2020)
Jenna A Dombroski, Nidhi Jyotsana, Davis W Crews, Zhenjiang Zhang, Michael R King
Fabrication and Characterization of Tumor Nano-Lysate as a Preventative Vaccine for Breast Cancer. Langmuir : the ACS journal of surfaces and colloids 36 (23) (2020)
Nidhi Jyotsana, Zhenjiang Zhang, Lauren E Himmel, Fang Yu, Michael R King
Minimal dosing of leukocyte targeting TRAIL decreases triple-negative breast cancer metastasis following tumor resection. Science advances 5 (7) (2019)